Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s share price fell 11.8% on Monday . The stock traded as low as GBX 4.05 ($0.05) and last traded at GBX 4.05 ($0.05). 4,219,608 shares traded hands during mid-day trading, an increase of 371% from the average session volume of 895,349 shares. The stock had previously closed at GBX 4.59 ($0.06).
Analyst Upgrades and Downgrades
Separately, Shore Capital reaffirmed a “house stock” rating on shares of Oxford BioDynamics in a research note on Tuesday, June 18th.
Check Out Our Latest Analysis on OBD
Oxford BioDynamics Stock Performance
About Oxford BioDynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Read More
- Five stocks we like better than Oxford BioDynamics
- Canadian Penny Stocks: Can They Make You Rich?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What Are Dividend Challengers?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.